Among neuropathologic features of AD pathology, however, diffuse plaques (DPs), comprised primarily of Aβ42, are typically abundant in these patients, also occurring in the absence of NFT–tau pathology, while neuritic plaques (NPs) comprised primarily of Aβ40 have mainly observed in AD patients [202]. The gene discussed is MAPT; the disease is Alzheimer disease.